Benjamin Creelan
8PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 09, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.Chao Wang, Xiaoqing Yu, Jamie K Teer
|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).Xiuning Le, Jyoti D Patel, Elaine Shum
|Sep 30, 2024
Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.Tyler J Alban, Nadeem Riaz, Prerana Parthasarathy
|Mar 07, 2022
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.Alberto A Chiappori, Ben Creelan, Tawee Tanvetyanon
|Aug 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.Benjamin C Creelan, Chao Wang, Jamie K Teer
|Oct 05, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.Benjamin C Creelan, Tammie C Yeh, Sang-We Kim
Pageof 2
Frequent Collaborators
2 joint publications
James J Saller
2 joint publications
Jose R Conejo-Garcia
2 joint publications
Theresa A Boyle
2 joint publications
John M Koomen
2 joint publications
Vladimir Makarov
2 joint publications
Timothy A Chan
2 joint publications
Jamie K Teer
2 joint publications
Don L Gibbons
1 joint publications
Michael Shafique
1 joint publications
Erick Morris
